Discover
SUPN
Supernus Pharmaceuticals, Inc.
42.67
2 x 33.83
2 x 56.00
bid
ask
+
0.53
1.26%
2 @ 05:34 PM
42.67 +0.00 (0.00%)
| Ytd | -14.14% | |
| 1y | -13.82% |
42.15
day range
43.13
41.28
52 week range
57.00
| Open | 42.18 | Prev Close | 42.14 | Low | 42.15 | High | 43.13 | Mkt Cap | 2.48B |
| Vol | 643.83K | Avg Vol | 756.95K | EPS | -1.92 | P/E | N/A | Forward P/E | 9.57 |
| Beta | 0.55 | Short Ratio | 8.64 | Inst. Own | 106.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 44.39 | 200-d Avg | 48.07 | 1yr Est | 61.75 |
| Income Statement | |||
| Total Revenue | 219.06M | ||
| Revenues (USD) | 219.06M | ||
| Cost of Revenue | 33.67M | ||
| Gross Profit | 185.39M | ||
| Operating Expenses | 243.35M | ||
| Research and Development Expense | 29.46M | ||
| Selling, General and Administrative Expense | 133.64M | ||
| Operating Income | -57.96M | ||
| Interest Expense | 2.32M | ||
| Income Tax Expense | 723.00K | ||
| Net Income | -58.37M | ||
| Net Income Common Stock | -58.37M | ||
| Net Income Common Stock (USD) | -58.37M | ||
| Consolidated Income | -58.37M | ||
| Earnings per Basic Share | -1.01 | ||
| Earnings per Basic Share (USD) | -1.01 | ||
| Earnings per Diluted Share | -1.01 | ||
| Earning Before Interest & Taxes (EBIT) | -55.33M | ||
| Earning Before Interest & Taxes (USD) | -55.33M | ||
| Weighted Average Shares | 58.07M | ||
| Weighted Average Shares Diluted | 58.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 181.40M | ||
| Cash and Equivalents (USD) | 181.40M | ||
| Investments | 192.11M | ||
| Investments Current | 192.11M | ||
| Trade and Non-Trade Receivables | 211.66M | ||
| Current Assets | 723.50M | ||
| Property, Plant & Equipment Net | 10.20M | ||
| Total Assets | 1.43B | ||
| Total Debt | 29.43M | ||
| Current Liabilities | 347.38M | ||
| Debt Non-Current | 29.43M | ||
| Total Liabilities | 396.88M | ||
| Accumulated Retained Earnings (Deficit) | 457.21M | ||
| Accumulated Other Comprehensive Income | -138.00K | ||
| Shareholders Equity | 1.03B | ||
| Shareholders Equity (USD) | 1.03B | ||
| Assets Non-Current | 704.61M | ||
| Total Debt (USD) | 29.43M | ||
| Goodwill and Intangible Assets | 588.89M | ||
| Inventory | 83.92M | ||
| Liabilities Non-Current | 49.51M | ||
| Trade and Non-Trade Payables | 108.46M | ||
| Tax Assets | 49.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 27.94M | ||
| Net Cash Flow from Financing | -7.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.92M | ||
| Capital Expenditure | -568.00K | ||
| Issuance (Purchase) of Equity Shares | 4.12M | ||
| Net Cash Flow from Investing | 7.09M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 7.66M | ||
| Net Cash Flow from Operations | -4.81M | ||
| Share Based Compensation | 8.64M | ||